A Phase 1 trial shows a personalized DNA vaccine (GNOS-PV01) is safe and doubles survival rates for aggressive glioblastoma.

Survival rate surpasses historical outcomes in a small phase I study ...

Participants in a clinical trial lived longer years longer after increased immune response to glioblastoma slowed progression ...

A personalized DNA vaccine for glioblastoma, an aggressive and incurable brain cancer, appears safe and shows early signs of ...

Promising trial results: A personalized DNA vaccine for glioblastoma doubled two-year survival rates in a small phase 1 trial and showed no serious side effects. How it works: The vaccine targets up ...

An investigational drug for glioblastoma more than doubled survival and progression-free time compared to standard rates, reported a new study published in Nature Communications. Glioblastoma is the ...

Temferon demonstrated potential in glioblastoma treatment, with long-term survivors and improved survival rates compared to historical data. The therapy reprograms the tumor microenvironment, inducing ...

Michael Bolton’s battle with glioblastoma has brought renewed attention to one of the most complex, deadly and treatment-resistant cancers. The singer, 72, told People he was diagnosed in December ...

18F-DOPA PET-guided proton beam therapy improved overall survival in older glioblastoma patients, with a median OS of 13.1 months and no grade 4 adverse events. The hypofractionated regimen, completed ...

A personalized vaccine to treat glioblastoma, a fast-growing and incurable brain cancer that affects four in 100,000 people ...